載入...

Identification of “Multiple Components-Multiple Targets-Multiple Pathways” Associated with Naoxintong Capsule in the Treatment of Heart Diseases Using UPLC/Q-TOF-MS and Network Pharmacology

Naoxintong capsule (NXT) is a commercial medicinal product approved by the China Food and Drug Administration which is used in the treatment of stroke and coronary heart disease. However, the research on the composition and mechanism of NXT is still lacking. Our research aimed to identify the absorb...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Xianghui Ma, Bin Lv, Pan Li, Xiaoqing Jiang, Qian Zhou, Xiaoying Wang, Xiumei Gao
格式: Artigo
語言:Inglês
出版: Hindawi Limited 2016-01-01
叢編:Evidence-Based Complementary and Alternative Medicine
在線閱讀:http://dx.doi.org/10.1155/2016/9468087
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!